Connect With a Global Community of 350+ mRNA Experts

As demand continues to rise for services spanning every stage of mRNA drug development, senior leaders across the mRNA sector are actively seeking partners who can offer tailored solutions to accelerate their pipelines grom early R&D through to full commercialization.

The 6th mRNA-Based Therapeutics Summit is your ultimate forum to connect directly with key decision makers and top CEO’s, showcasing your technology to those that need your solutions. If your organization offers capabilities that support the advancement of mRNA therapeutics, we invite you to position your brand at the heart of this growing community.

Contact us to promote your brand through a bespoke commercial package at next year's event. Email sponsor@hansonwade.com to request more information.

What Can You Expect?

Meeting New Clients

Expand your client base within the mRNA community by networking face-to-face with large pharma and new biotechs actively seeking solutions to overcome their drug development challenges.

Centring Yourself in Biopharma Dealmaking

Position your brand in front of C-Level decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.

Demonstrating Your Expertise

Present your work within one of our focused tracks, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.

Gaining Market Intelligence

Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.

Key Services & Solutions

Our attendees from mRNA biopharma were looking for service and solution providers with capabilities in the below areas but not limited to:

1

Trailblazing mRNA-LNP Design, Screening & Synthesis Methods

2

Optimizing Analytical Tools for mRNA Release & Nanoparticle Stability

3

Harmonizing Regulatory Documentation Guidance to De-Risk mRNA Drug Approval

4

Pioneering Delivery Solutions & Platform Innovations

5

Improving Pre-Clinical Assays for Potency & Immunogenicity Studies

6

Advancing Clinical Trial Development & Recruitment

7

Utilizing Novel Technologies for mRNA Drug Manufacturing & Scale Up

8

Increasing Marketing Access & Commercialization Planning

Partnership Opportunities

Present

Data-driven or case study- led presentations to position yourself as a thought leader

Exhibit

Showcase your solutions at the centre of the exhibitor space and stand out from amongst the competition

Full Delegate List

Exclusive access to the Full Delegate List to plan your conversations in advance

Branding

LANYARDS SOLD OUT.

On-site and website branding to highlight your company at the forefront of the mRNA space

Network

Organized networking to generate commercial collaborations

Drinks Reception

HOSTED LUNCH SOLD OUT.

Drinks reception, or dinner for exclusive time with your target audience.

Hear What Our Past Sponsors Have to Say

Ansa Biotechnologies Logo

The Hanson Wade 5th Annual mRNA summit was a great meeting. I really enjoyed the ability to network with potential customers and learn about their research. It is a great event for good scientific discussions and networking.

Ansa Biotechnologies

Intertek 5th mRNA-Based Therapeutics Summit

The quality of talks and people attending is very impressive.

Intertek

Attending Companies Include

Get in Touch

William Hobson-Corbett

Senior Business Development Manager
RNA Therapy Events

mRNA23-107
Maintain Your Competitive Edge

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma discussions.

mRNA23-207
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and speed networking opportunities.

networking-glance
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's objectives in 2026/27.